Bixiye
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2961 - 2970 ee natiijooyinka 3167
Bixiye
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
QP33-17 ICD-10 Grouper Updates
Taariikhda uu dhaqangalayo barnaamijka: Okt 17, 2017
Bixiye
P56-17 Implementation of a Medical Drug Exclusions List
Taariikhda uu dhaqangalayo barnaamijka: Okt 16, 2017
Bixiye
QP32-17 Pharmacy Benefit Update - Dispense as Written (DAW) 1 Clarification
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2017
Bixiye
P55-17 Prior Authorization Requirement for Orthognathic Surgery
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2017
Bixiye
P54-17 Clarification to Commercial Prior Authorization Requirements for Early Intensive Behavioral Intervention (EIBI)
Taariikhda uu dhaqangalayo barnaamijka: Okt 10, 2017
Bixiye
P53-17 New Drug-Related Prior Authorization Requirements for Edaravone (Radicava) and Cerliponase Alfa (Brineura)
Taariikhda uu dhaqangalayo barnaamijka: Okt 10, 2017
Bixiye
QP31-17 New Pre-Authorization Form for Infliximab
Taariikhda uu dhaqangalayo barnaamijka: Okt 05, 2017
Bixiye
P52-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Parathyroid Hormone Analog for Osteoporosis
Taariikhda uu dhaqangalayo barnaamijka: Okt 03, 2017